Literature DB >> 10343928

Adverse events associated with commonly used glaucoma drugs.

R Vogel1, E Strahlman, K D Rittenhouse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10343928     DOI: 10.1097/00004397-199903920-00009

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  4 in total

1.  In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.

Authors:  Hee Young Choi; Ji Eun Lee; Ji Woong Lee; Hyun Jun Park; Ji Eun Lee; Jae Ho Jung
Journal:  J Ocul Pharmacol Ther       Date:  2011-11-22       Impact factor: 2.671

2.  Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.

Authors:  Juwan Park; Hyun Kyung Cho; Jung-Il Moon
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

Review 3.  Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  Risto S Cvetkovic; Caroline M Perry
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Topical prostaglandin analogue drugs inhibit adipocyte differentiation.

Authors:  Jae Woo Kim
Journal:  Korean J Ophthalmol       Date:  2014-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.